Compare TIL & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIL | ARAY |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 170.1M |
| IPO Year | 2021 | 2007 |
| Metric | TIL | ARAY |
|---|---|---|
| Price | $11.32 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $100.67 | $4.50 |
| AVG Volume (30 Days) | 73.2K | ★ 1.2M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $10.70 | $0.91 |
| 52 Week High | $42.79 | $2.95 |
| Indicator | TIL | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 45.46 |
| Support Level | $10.76 | $0.95 |
| Resistance Level | $11.51 | $1.06 |
| Average True Range (ATR) | 0.88 | 0.07 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 24.64 | 80.99 |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.